LSB Industries vs Valhi
LXU and VHI side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How LXU and VHI compare
LSB Industries is the larger company, worth 1.6 times as much as Valhi ($760M against $470M).
LSB Industries grew revenue faster over the last twelve months (13.0% versus 3.4% for Valhi).
LSB Industries keeps more of each dollar of sales as profit, with a net margin of 7.0% compared with −2.4% at Valhi.
Valhi pays a dividend yielding 1.9%; LSB Industries does not pay one.
LSB Industries scores higher on the StockData Score (12 against 7 for Valhi), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | LXU | VHI |
|---|---|---|
| Size and price | ||
| Market cap | $760M | $470M |
| Share price | $10.56 | $16.58 |
| Change, 1 year | 8.8% | 31.7% |
| Change, 5 years | 4.3% | −37.9% |
| Beta (5Y) | −1.44 | 0.09 |
| Employees | 513 | 549 |
| StockData Score | ||
| Total score | 12 (better) | 7 |
| Valuation score | 5 (better) | 3 |
| Growth score | 2 (better) | 0 |
| Performance score | 2 (better) | 0 |
| Health score | 3 (better) | 2 |
| Dividend score | 0 | 2 (better) |
| Valuation | ||
| P/E | 17.0× | – |
| P/S | 1.1× | 0.2× (better) |
| P/B | 1.4× | 0.4× (better) |
| EV/EBITDA | 6.2× (better) | 8.2× |
| P/FCF | 11.9× | 7.5× (better) |
| FCF yield | 8.4% | 13.4% (better) |
| Fair value | $15.11 | $43.54 |
| Margin of safety | 30.1% | 61.9% (better) |
| Growth | ||
| Revenue growth (TTM) | 13.0% (better) | 3.4% |
| Revenue growth, 5Y average | 11.9% (better) | 2.3% |
| Net income growth (TTM) | – | −152% |
| Profitability | ||
| Gross margin | 19.9% (better) | 14.7% |
| Operating margin | 11.2% (better) | 3.6% |
| Net margin | 7.0% (better) | −2.4% |
| FCF margin | 9.7% (better) | 2.9% |
| Return on equity | 8.7% (better) | −4.8% |
| Return on invested capital | 8.2% (better) | 4.2% |
| Financial health | ||
| Debt / equity | 0.79 | 0.56 (better) |
| Net debt / EBITDA | 1.48 (better) | 2.56 |
| Interest coverage | 2.6× (better) | 1.3× |
| Current ratio | 3.01 | 3.37 (better) |
| Altman Z-score | 1.95 (better) | 1.87 |
| Piotroski F-score | 8 (better) | 3 |
| Dividends and buybacks | ||
| Dividend yield | – | 1.9% |
| Years of dividend growth | – | 0 |
| Dividend growth, 5Y average | – | −7.8% |
| Shareholder yield | 0.00% | 1.9% (better) |
| Ownership | ||
| Held by institutions | 71.7% | 4.2% |
| Held by insiders | 24.4% | 0.26% |
| Insider net buying, 12 months | −$81.9M | – |
| Short interest, % of float | 6.8% | 0.21% |
Go deeper
- LXU stock overview
- LXU income statement
- LXU valuation and score
- VHI stock overview
- VHI income statement
- VHI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.